Burzynski Research Institute, Inc. (BZYR)
PNK · Healthcare · Biotechnology
$0.01
+0.00%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.1M
Shares Outstanding
131.4M
Exchange
PNK
Currency
USD
About Burzynski Research Institute, Inc.
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Quarterly Financials
| Metric | 2024-11-30 | 2025-02-28 | 2025-05-31 | 2025-11-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -352K | -293K | -331K | -329K |
| Net Income | -352K | -293K | -331K | -329K |
| Diluted EPS | $0.00 | $nan | $0.00 | $0.00 |
Annual Financials
| Metric | 2022-02-28 | 2023-02-28 | 2024-02-29 | 2025-02-28 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -977K | -916K | -1.3M | -1.4M |
| Net Income | -977K | -916K | -1.3M | -1.4M |
| Diluted EPS | $-0.01 | $-0.01 | $-0.01 | $-0.01 |